|
1
|
Meshkani R and Adeli K: Hepatic insulin
resistance, metabolic syndrome and cardiovascular disease. Clin
Biochem. 42:1331–1346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shearn CT, Fritz KS, Reigan P and Petersen
DR: Modification of Akt2 by 4-hydroxynonenal inhibits
insulin-dependent Akt signaling in HepG2 cells. Biochemistry.
50:3984–3996. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Henriksen EJ and Dokken BB: Role of
glycogen synthase kinase-3 in insulin resistance and type 2
diabetes. Curr Drug Targets. 7:1435–1441. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schinner S, Scherbaum WA, Bornstein SR and
Barthel A: Molecular mechanisms of insulin resistance. Diabet Med.
22:674–682. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nawano M, Oku A, Ueta K, et al:
Hyperglycemia contributes insulin resistance in hepatic and adipose
tissue but not skeletal muscle of ZDF rats. Am J Physiol Endocrinol
Metab. 278:E535–E543. 2000.PubMed/NCBI
|
|
6
|
Ramachandran D, Roy U, Garg S, et al:
Sirt1 and mir-9 expression is regulated during glucose-stimulated
insulin secretion in pancreatic β-islets. FEBS J. 278:1167–1174.
2011.PubMed/NCBI
|
|
7
|
Joglekar MV, Parekh VS and Hardikar AA:
Islet-specific microRNAs in pancreas development, regeneration and
diabetes. Indian J Exp Biol. 49:401–408. 2011.PubMed/NCBI
|
|
8
|
Poy MN, Hausser J, Trajkovski M, et al:
miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc
Natl Acad Sci USA. 106:5813–5818. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kornfeld JW, Baitzel C, Könner AC, et al:
Obesity-induced overexpression of miR-802 impairs glucose
metabolism through silencing of Hnf1b. Nature. 494:111–115. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Y, Song Y, Wang Z, et al: Altered
expression of MiR-148a and MiR-152 in gastrointestinal cancers and
its clinical significance. J Gastrointest Surg. 14:1170–1179. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang WY, Lee JJ, Kim Y, et al:
Amelioration of insulin resistance by scopoletin in
high-glucose-induced, insulin-resistant HepG2 cells. Horm Metab
Res. 42:930–935. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakatani Y, Kaneto H, Kawamori D, et al:
Modulation of the JNK pathway in liver affects insulin resistance
status. J Biol Chem. 279:45803–45809. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ramey G, Deschemin JC and Vaulont S:
Cross-talk between the mitogen activated protein kinase and bone
morphogenetic protein/hemojuvelin pathways is required for the
induction of hepcidin by holotransferrin in primary mouse
hepatocytes. Haematologica. 94:765–772. 2009. View Article : Google Scholar
|
|
14
|
Mao Y, Mohan R, Zhang S and Tang X:
MicroRNAs as pharmacological targets in diabetes. Pharmacol Res.
75:37–47. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakajima K, Yamauchi K, Shigematsu S, et
al: Selective attenuation of metabolic branch of insulin receptor
down-signaling by high glucose in a hepatoma cell line, HepG2
cells. J Biol Chem. 275:20880–20886. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Y, Song Y, Wang Z, et al: Altered
expression of MiR-148a and MiR-152 in gastrointestinal cancers and
its clinical significance. J Gastrointest Surg. 14:1170–1179. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Braconi C, Huang N and Patel T:
MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor
suppressor gene expression by interleukin-6 in human malignant
cholangiocytes. Hepatology. 51:881–890. 2010.PubMed/NCBI
|
|
18
|
Tsuruta T, Kozaki K, Uesugi A, et al:
MiR-152 is a tumor suppressor microRNA that is silenced by DNA
hypermethylation in endometrial cancer. Cancer Res. 71:6450–6462.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hino R, Uozaki H, Murakami N, et al:
Activation of DNA methyltransferase 1 by EBV latent membrane
protein 2A leads to promoter hypermethylation of PTEN gene in
gastric carcinoma. Cancer Res. 69:2766–2774. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kang MY, Lee BB, Kim YH, et al:
Association of the SUV39H1 histone methyltransferase with the DNA
methyltransferase 1 at mRNA expression level in primary colorectal
cancer. Int J Cancer. 121:2192–2197. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ji W, Yang L, Yuan J, et al: MicroRNA-152
targets DNA methyltransferase 1 in NiS-transformed cells via a
feedback mechanism. Carcinogenesis. 34:446–453. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang J, Wang Y, Guo Y and Sun S:
Down-regulated microRNA-152 induces aberrant DNA methylation in
hepatitis B virus-related hepatocellular carcinoma by targeting DNA
methyltransferase 1. Hepatology. 52:60–70. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Braconi C, Huang N and Patel T:
MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor
suppressor gene expression by interleukin-6 in human malignant
cholangiocytes. Hepatology. 51:881–890. 2010.PubMed/NCBI
|
